Abstract: Provided are a GPS coordinates-based target overall planning method and a camera. Said method comprises: acquiring the GPS coordinates of each tracking target (S101); for each pre-divided region, counting the number of tracking targets located in the region based on the acquired GPS coordinates of each tracking target (S102); generating a heat map of the tracking targets based on the number of the tracking targets in each region (S103). Hence, in the present method, a device generates a heat map based on the GPS coordinates of tracking targets, and the heat map can reflect the number of the tracking targets in each region, achieving the overall planning of the tracking targets.

Abstract: Provided herein are an indene compound, e.g., a compound of Formula (I), and a pharmaceutical composition thereof. Also provided herein is a method of their use for treating, preventing, or ameliorating one or more symptoms of a fibrotic disease.

Abstract: A leaflet capture device and system, and an assembling method. The leaflet capture device comprises: a wire body configured to be spiral and comprising a distal coil, an intermediate coil, and a proximal coil which are arranged in sequence; and a proximal joint comprising a proximal joint main body portion, a proximal clamping jaw, and a proximal clamping portion.

Abstract: A leaflet capture device and system, and an assembling method. The leaflet capture device comprises: a wire body (1) configured to be spiral and comprising a distal coil (10), an intermediate coil (20), and a proximal coil (30) which are arranged in sequence; and a proximal joint (12) comprising a proximal joint main body portion (120), a proximal clamping jaw (121), and a proximal clamping portion (122).

Abstract: Provided herein are an indene compound, e.g., a compound of Formula (I), and a pharmaceutical composition thereof. Also provided herein is a method of their use for treating, preventing, or ameliorating one or more symptoms of a fibrotic disease.

Abstract: The present disclosure discloses a control handle, which includes an outer clamp arm control mechanism and an inner clamp arm control mechanism. The outer clamp arm control mechanism may be configured to control the movement of an outer clamp arm of a tissue clamping device, and include a sleeve, a first control part, and a sliding part. The sliding part may be disposed in the sleeve. The first control part may rotate to drive the sliding part to move in the sleeve along a length direction of the sleeve, so as to control the opening and closing of the outer clamp arm. The inner clamp arm control mechanism may be configured to control the movement of an inner clamp arm of the tissue clamping device, and include a housing and a second control part. The second control part may pass through and move along a second sliding groove to control the opening and closing of the inner clamp arm relative to the outer clamp arm.

Abstract: A prosthetic mitral annuloplasty ring includes a wire, an adjustment member for changing a length of the wire and a jacketing annulus for adjusting a radial dimension of the mitral valve annuloplasty ring. The jacketing annulus is sleeved over the wire and forms, together with the adjustment member, a shape matching that of a native mitral valve annulus. After the prosthetic mitral annuloplasty ring is implanted by suturing in a conventional surgical procedure and the patient's heart starts to beat again, the adjustment member can be connected to the delivery device and the wire length therein can be adjusted by a rotating operation of the delivery device so that the mitral valve annuloplasty ring will be expanded or contracted until the prosthetic mitral annuloplasty ring perfectly fits the native mitral valve annulus in shape, effectively avoiding the problem of incomplete mitral leaflet coaptation.

Abstract: An artificial cardiac valve is disclosed, which includes an outer stent; an inner stent nested within and connected to the outer stent; leaflets disposed inside the inner stent; and membranes attached to walls of the outer and inner stents. The inner stent is a cylindrical mesh tube, and the outer stent includes a first stent segment, a second stent segment and a third stent segment which are connected sequentially. The first stent segment is a mesh tube. The second stent is a mesh tube having a substantially D-shaped cross-section, and the third stent segment is a flared mesh tube. The first stent segment has a maximum diameter that is equal to a diameter of the second stent segment and to a minimum diameter of the third stent segment. In this stent design, the inner stent can withstand traction forces from the leaflets, and the outer stent is adapted to match the anatomy of the native valve.

Abstract: A drive handle and system for delivering an implant are disclosed. The drive handle includes a manual control unit, an electrical control unit and a transmission mechanism. The manual control unit is connected to the transmission mechanism to actuate the transmission mechanism to drive a delivery catheter for delivering the implant. The electrical control unit is connected to the transmission mechanism to actuate the transmission mechanism to drive the delivery catheter. The drive handle is switchable between a manual drive/control mode and an electrical drive/control mode to drive the delivery catheter to deliver the implant. The operation is simple, and the operating physician can take full advantage of the two modes to perform the surgical procedure based on his/her own operational preferences. This can result in higher surgical accuracy. Further, by providing these two modes, the apparatus has an increased the security and a reduced surgical risk.

Abstract: A prosthetic mitral annuloplasty ring includes a wire, an adjustment member for changing a length of the wire and a jacketing annulus for adjusting a radial dimension of the mitral valve annuloplasty ring. The jacketing annulus is sleeved over the wire and forms, together with the adjustment member, a shape matching that of a native mitral valve annulus. After the prosthetic mitral annuloplasty ring is implanted by suturing in a conventional surgical procedure and the patient's heart starts to beat again, the adjustment member can be connected to the delivery device and the wire length therein can be adjusted by a rotating operation of the delivery device so that the mitral valve annuloplasty ring will be expanded or contracted until the prosthetic mitral annuloplasty ring perfectly fits the native mitral valve annulus in shape, effectively avoiding the problem of incomplete mitral leaflet coaptation.

Abstract: An artificial cardiac valve is disclosed, which includes an outer stent; an inner stent nested within and connected to the outer stent; leaflets disposed inside the inner stent; and membranes attached to walls of the outer and inner stents. The inner stent is a cylindrical mesh tube, and the outer stent includes a first stent segment, a second stent segment and a third stent segment which are connected sequentially. The first stent segment is a mesh tube. The second stent is a mesh tube having a substantially D-shaped cross-section, and the third stent segment is a flared mesh tube. The first stent segment has a maximum diameter that is equal to a diameter of the second stent segment and to a minimum diameter of the third stent segment. In this stent design, the inner stent can withstand traction forces from the leaflets, and the outer stent is adapted to match the anatomy of the native valve.

Abstract: An implant capsule (10) and an implant delivery system are disclosed. The implant capsule (10) includes, sequentially from a proximal end to a distal end, a flexural section (102, 102a-102e), a reinforcement section (101, 101a-101e) and a radiopaque reinforcement ring (104a-104e). The reinforcement section (101, 101a-101e) has higher strength than the flexural section (102, 102a-102e). The implant delivery system includes the implant capsule (10). The implant capsule (10) can ensure the implant to be deployed in a coaxial condition and prevent over-expansion due to large expansion forces exerted by a stent of the implant.

Abstract: A device and method for loading an implant into a delivery system are disclose which are capable of simplifying operations required in interventional surgery using the implant. The device includes a guide cap (1), a guider (2) and a guiding tube (3). The guide cap (1) has a conical section (101) and a straight or conical tube (103) in communication with a small open end (102) of the conical section, and the conical section has a large open end (104) that flares outward, thereby forming a flange (105) facing the tube (103). The guider (2) has tapered sections (9, 10) that are tapered along an axis of the guider and thus form large and small open ends (8, 11). The small open end (11) has a diameter greater than a diameter of the small open end (102) of the conical section of the guide cap (1).

Abstract: The present invention relates to fused pyrimidine-based hydroxamate compounds of formula (I), comprising a hydroxamate group, that are inhibitors of hiStone deacetylase (HDAC) and kinases. More particularly, the present invention relates to hydroxamate substituted purine or 5H-pyrrolo[3,2-d]pyrimidine derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of disorders/conditions/diseases involving, relating to or associated with enzymes having histone deacetylase, non-histone deacetylase and kinase activities/functions and/or via unspecified/multi-targeted mechanisms.

Abstract: An electric handle for delivering an implant is disclosed. The electric handle (1) includes an electric control unit (10), a power-driven transmission mechanism (20), a handle housing (30), an outer tube anchor (40) and an inner tube anchor (50), wherein: the electric control unit (10) is operatively coupled to the power-driven transmission mechanism (20) to actuate the power-driven transmission mechanism (20); the power-driven transmission mechanism (20) is supported within the handle housing (30) and moveable together with the outer tube anchor (40); the inner tube anchor (50) is disposed within the handle housing (30) and is configured to hold an inner tube (3) of a delivery system; and the outer tube anchor (40) is configured to hold an outer tube (2) of the delivery system and is fixed to an end of the outer tube (2). A delivery system used especially for delivery of prosthetic valves is also disclosed, including an outer tube (2), an inner tube (3), an expandable implant (4) and the electric handle (1).

Abstract: The present invention relates to fused pyrimidine-based hydroxamate compounds of formula (I), comprising a hydroxamate group, that are inhibitors of histone deacetylase (HDAC) and kinases. More particularly, the present invention relates to hydroxamate substituted purine or 5H-pyrrolo[3,2-d]pyrimidine derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of disorders/conditions/diseases involving, relating to or associated with enzymes having histone deacetylase, non-histone deacetylase and kinase activities/functions and/or via unspecified/multi-targeted mechanisms.

Abstract: A drive handle and system for delivering an implant are disclosed. The drive handle includes a manual control unit, an electrical control unit and a transmission mechanism. The manual control unit is connected to the transmission mechanism to actuate the transmission mechanism to drive a delivery catheter for delivering the implant. The electrical control unit is connected to the transmission mechanism to actuate the transmission mechanism to drive the delivery catheter. The drive handle is switchable between a manual drive/control mode and an electrical drive/control mode to drive the delivery catheter to deliver the implant. The operation is simple, and the operating physician can take full advantage of the two modes to perform the surgical procedure based on his/her own operational preferences. This can result in higher surgical accuracy. Further, by providing these two modes, the apparatus has an increased the security and a reduced surgical risk.

Abstract: An implant delivery system is disclosed which includes an inner tube assembly, an outer tube assembly and a functional handle. The functional handle includes a threaded rod, a push-pull control member, a casing tube, a displacement tube, an inner tube fixing member, an outer tube fixing member and a stability tube fixing member. The threaded rod extends through a bore of the displacement tube. A fastener of the push-pull control member is able to engage a thread provided on a leading portion of the threaded rod. A trailing portion of the threaded rod is provided with a knob. The push-pull control member includes a fastener, springs and a button. The fastener is able to extend through a slot to engage a thread of the threaded rod in the displacement tube. The springs are configured to cause an automatic locking of the fastener and the threaded rod. The button is provided on the fastener.

Abstract: The present invention relates to fused R1 pyrimidine-based hydroxamate compounds of formula (I), comprising a hydroxamate group, that are inhibitors of histone deacetylase (HDAC) and kinases. More particularly, the present invention relates to hydroxamate substituted purine or 5H-pyrrolo[3,2-d]pyrimidine derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of disorders/conditions/diseases involving, relating to or associated with enzymes having histone deacetylase, non-histone deacetylase and kinase activities/functions and/or via unspecified/multi-targeted mechanisms.

Abstract: An implant capsule (10) and an implant delivery system are disclosed. The implant capsule (10) includes, sequentially from a proximal end to a distal end, a flexural section (102, 102a-102e), a reinforcement section (101, 101a-101e) and a radiopaque reinforcement ring (104a-104e). The reinforcement section (101, 101a-101e) has higher strength than the flexural section (102, 102a-102e). The implant delivery system includes the implant capsule (10). The implant capsule (10) can ensure the implant to be deployed in a coaxial condition and prevent over-expansion due to large expansion forces exerted by a stent of the implant.